Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis()

por Herath, Chandana B., Warner, Fiona J., Lubel, John S., Dean, Rachael G., Jia, Zhiyuan, Lew, Rebecca A., Smith, A. Ian, Burrell, Louise M., Angus, Peter W.
Publicado 2007

Substituted imidazopyridines as potent inhibitors of HCV replication()

por Vliegen, Inge, Paeshuyse, Jan, De Burghgraeve, Tine, Lehman, Laura S., Paulson, Matthew, Shih, I-Hung, Mabery, Eric, Boddeker, Nina, De Clercq, Erik, Reiser, Hans, Oare, David, Lee, William A., Zhong, Weidong, Bondy, Steven, Pürstinger, Gerhard, Neyts, Johan
Publicado 2009

A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients()

por Puoti, Massimo, Zanini, Barbara, Quinzan, Gian Paolo, Ravasio, Laura, Paraninfo, Giuseppe, Santantonio, Teresa, Rollo, Adriano, Artioli, Stefania, Maggiolo, Franco, Zaltron, Serena, MASTER HIV/HCV Co-infection study group, Raise, Enzo, Mignani, Ermenegildo, Resta, Francesco, Verucchi, Gabriella, Pastore, Giuseppe, Suter, Fredy, Carosi, Giampiero
Publicado 2004

Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?

por Craxì, Antonio, Lo Iacono, Oreste
Publicado 2001